← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Abcombi Biosciences, Inc.
Buffalo, NY
$3,387,435
Total funding
4
Grants
Funding over time
peak $940.5K · FY2016–22$1M$750K$500K$250K$0
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$3,162,435 · 3
NSF$225,000 · 1
By mechanism
R44$2,512,535 · 1
R41$349,900 · 1
R43$300,000 · 1
—$225,000 · 1
Investigators at Abcombi Biosciences, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
DEVELOPMENT OF A LIPOSOMAL PNEUMOCOCCAL VACCINE FOR CLINICAL READINESS$940,483
R44 · FY2021 · AI
DEVELOPMENT OF A LIPOSOMAL PNEUMOCOCCAL VACCINE FOR CLINICAL READINESS$856,101
R44 · FY2022 · AI
DEVELOPMENT OF A LIPOSOMAL PNEUMOCOCCAL VACCINE FOR CLINICAL READINESS$715,951
R44 · FY2020 · AI
Therapy for drug resistant influenza strains by nucleic acid targeting of respiratory airways$300,000
R41 · FY2016 · AI
Lead Candidate Finalization and a Comprehensive Biological Assessment of a New Class of Pneumococcal Vaccines$300,000
R43 · FY2018 · AI
SBIR Phase I: Treatment technology for recovery of valuable metals from industrial wastewater$225,000
· FY2016 · TIP
Therapy for drug resistant influenza strains by nucleic acid targeting of respiratory airways$49,900
R41 · FY2017 · AI